Georgia's Online Cancer Information Center

Standard Operating Procedures for Clinical Trials

SOP Title
   
General Administration (GA)
GA-101.02 SOP on SOPs: Preparing, Maintaining and Training
GA-102.02 Sponsor Responsibility and Delegation of Responsibility
GA-103.02 Training and Education
GA-104.01 Document Development and Change Control
   
Study Start-Up (SS)
SS-201.04 Assessing Protocol Feasibility
SS-202.01 Investigator Selection
SS-203.02 Pre-Study Site Visit (PSSV)
   
Study Management (SM)
SM-301.01 Communication
SM-303.02 Documentation and Records Retention
SM-304.01 Routine Monitoring Visits
SM-305.01 Closeout Visits
SM-306.01 Adverse Event Reporting
SM-307.01 Investigational Product Management
SM-308.02 Specimen Management
   
Data Management (DM)
DM-401.01 Data Management
   
Privacy Practices (PP)
PP-501.01 Safeguarding Protected Health Information
   
Quality Assurance (QA)
QA-601.02 FDA or Pharmaceutical Sponsored Audits
   

Last Updated: 2/18/2021 2:46:25 PM

Clinical Trials, Doctors & Cancer Centers

Georgia CORE to support new trials network

An Emory-led, LLS-funded cancer clinical trials network will increase access for blood cancer patients across the state.

2/07/2024

 Clinical Trials, Doctors & Cancer Centers

‘It’s working!’ Columbus cancer center is first in Georgia to administer this new therapy

Health care providers at the John B. Amos Cancer Center in Columbus, Georgia are the first in the state to administer a new therapy for cancer treatment, called BiTE therapy.

2/14/2025

Georgia CORE introduces a resource guide for barriers to cancer clinical trials

We invite you to download and share it, and let us know if there is anything we should add to it.

1/14/2025